Product
GEH200520 + GEH200521 (18F)
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Phase 1, Single-Center, Open-Label, Single-Arm, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety and Tolerability, Immunogenicity, Pharmacokinetics, Dosimetry and Biodistribution Following GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2025-05-01